N. Shiff

Efficacy and Safety of Intravenous Golimumab in Patients With Ankylosing Spondylitis and Complete Spinal Ankylosis

J. Reveille, A. Deodhar, K. Lo, 2022, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Efficacy and Safety of Intravenous Golimumab in Ankylosing Spondylitis Patients With Early and Late Disease Through One Year of the GO-ALIVE Study

J. Reveille, A. Deodhar, K. Lo, 2022, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Improvement in disease activity among patients with rheumatoid arthritis who switched from intravenous infliximab to intravenous golimumab in the ACR RISE registry

G. Schmajuk, N. Hammam, S. Chakravarty, 2022, Clinical Rheumatology.

Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study

P. Mease, A. Kollmeier, Xie L. Xu, 2024, RMD open.

Clinical Characteristics of Registry Participants with Psoriatic Arthritis Initiating Guselkumab: An Analysis from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

A. Ogdie, P. Mease, A. Kavanaugh, 2022, Drugs - Real World Outcomes.

POS1017 GUSELKUMAB PROVIDES CONTINUED IMPROVEMENT IN KEY DOMAINS OF PSORIATIC ARTHRITIS THROUGH 2 YEARS

L. Gossec, E. Rampakakis, P. Nash, 2022, Annals of the Rheumatic Diseases.

Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

A. Ogdie, P. Mease, J. Merola, 2023, Rheumatology and Therapy.

Work Productivity and General Health Through 2 Years of Guselkumab Treatment in a Phase 3 Randomized Trial of Patients With Active Psoriatic Arthritis

D. Gladman, P. Mease, A. Kollmeier, 2024, Rheumatology and therapy.

The Effect of Guselkumab on General Health State in Biologic-Naïve Patients with Active Psoriatic Arthritis Through Week 52 of the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Trial

D. Gladman, W. Tillett, P. Rahman, 2022, Advances in Therapy.

Teens Taking Charge: A Randomized Controlled Trial of a Web-Based Self-Management Program With Telephone Support for Adolescents With Juvenile Idiopathic Arthritis

Amos S Hundert, J. Stinson, C. Lalloo, 2020, Journal of medical Internet research.

Improvements in Patient‐Reported Outcomes Through Six Months of Guselkumab Treatment in Patients With Active Psoriatic Arthritis: Real‐World Data From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

P. Mease, S. Chakravarty, A. Broadwell, 2024, ACR open rheumatology.